Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03281369
Title A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

gastroesophageal junction adenocarcinoma

esophageal cancer

gastric adenocarcinoma

Therapies

Atezolizumab + Cobimetinib

Atezolizumab + Cisplatin + Fluorouracil + Tiragolumab

Atezolizumab + Cisplatin + Fluorouracil

Atezolizumab + Cobimetinib + Fluorouracil + Leucovorin + Oxaliplatin

Atezolizumab + Fluorouracil + Leucovorin + Oxaliplatin

Atezolizumab + Linagliptin

Atezolizumab + PEGPH20

Atezolizumab + BKT140

Paclitaxel + Ramucirumab

Cisplatin + Fluorouracil

Fluorouracil + Leucovorin + Oxaliplatin

Atezolizumab + Tiragolumab

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.